Summary
Bcl-xL, an anti-apoptotic member of the Bcl-2 family, has been generally thought to be involved in the regulation of apoptosis in the liver, because this molecule tends to be upregulated during liver regeneration, as well as in certain types of liver injury. We employed a Cre/loxP conditional knockout model and found that deletion of the bcl-x gene resulted in accelerated apoptosis in hepaocytes in vivo, formally proving the critical role of this molecule in maintaining hepatocyte integrity. Furthermore, Bcl-xL may play an important role during hepatocarcinogenesis, because one-third of human hepatocellular carcinoma (HCC) tissues showed increased expression of Bcl-xL and its knockdown by antisense oligonueleotide stimulated apoptosis in hepatoma cells in response to cellular stresses, such as serum starvation, p53 activation, and staurosporine treatment. It was also found that Bcl-xL was post-translationally modified by deamidation in its loop domain in human liver tissues; deamidated Bcl-xL is a major form in normal liver tissues, whereas the level of deamidated Bcl-xL is lower than that of unmodified Bcl-xL in the majority of HCC tissues. As protein deamidation of Bcl-xL leads to a complete “loss of function” of this antiapoptotic molecule, HCCs may acquire resistance to apoptosis and a survival advantage by suppressing the deamidation, as well as by increasing the expression of Bcl-xL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899–1911
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229–240
Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, De Kretser D, Metcalf D, Kontgen F, Adams JM, Cory S (1998) Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci USA 95: 12424–12431
Ross AJ, Waymire KG, Moss JE, Parlow AF, Skinner MK, Russell LD, MacGregor GR (1998) Testicular degeneration in Bclw-deficient mice. Nat Genet 18:251–256
Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Nakayama K, Hatakeyama S (1998) Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 188:1985–1992
Russell HR, Lee Y, Miller HL, Zhao J, McKinnon PJ (2002) Murine ovarian development is not affected by inactivation of the Bcl-2 family member Diva. Mol Cell Biol 22: 6866–6870
Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506–1510
Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ (2000) Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 14:23–27
Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC, Steer CJ (1996) Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. Cell Growth Differ 12:1633–1642
Tzung SP, Fausto N, Hockenbery DM (1997) Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 150:1985–1995
Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, Nguyen VA, Gao B (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110:1503–1513
Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I (1995) Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nueleic Acids Res 23:3816–3821
Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi T (2001) Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34:55–61
Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T (1998) Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res 58: 3331–3338
Robinson AB, Rudd CJ (1974) Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Curr Top Cell Regul 8:247–295
Aswad DW, Paranandi MV, Schurter BT (2000) Isoaspartate in peptides and proteins: formation, significance, and analysis. J Pharm Biomed Anal 21:1129–1136
Robinson NE (2002) Protein deamidation. Proc Natl Acad Sci USA 99:5283–5288
Takehara T, Takahashi H (2000) Bcl-xL is posttranslationally deamidated at asparagine residues (abstract). FASEB J 15:A1517
Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ (2002) Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111:51–62
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Japan
About this paper
Cite this paper
Takehara, T., Hayashi, N. (2004). Bcl-xL as a Critical Apoptosis Antagonist in Hepatocytes and Hepatocellular Carcinoma. In: Okita, K. (eds) Stem Cell and Liver Regeneration. Springer, Tokyo. https://doi.org/10.1007/978-4-431-53971-1_7
Download citation
DOI: https://doi.org/10.1007/978-4-431-53971-1_7
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67972-1
Online ISBN: 978-4-431-53971-1
eBook Packages: Springer Book Archive